A complete guide to Type 1 diabetes management — insulin dosing, DKA prevention, CGM vs glucometer — with expert top 5 picks for blood glucose monitors for T1D.
Type 1 diabetes is an autoimmune disease where the immune system destroys insulin-producing beta cells in the pancreas. Without insulin, blood sugar rises to dangerous levels. Lifelong insulin therapy and blood glucose monitoring are essential.
Type 1 diabetes (T1D) is an autoimmune disease in which the immune system destroys the insulin-producing beta cells of the pancreas. Unlike Type 2 diabetes, T1D is not caused by lifestyle factors — it is an absolute insulin deficiency requiring lifelong insulin replacement. It affects approximately 1.9 million Americans and is most commonly diagnosed in children and young adults, though it can develop at any age.
Blood glucose monitoring is not optional in T1D — it is the central act of disease management. People with T1D must make insulin dosing decisions multiple times daily based on their current glucose level, carbohydrate intake, planned activity, and recent trends. A glucometer (or increasingly, a continuous glucose monitor) is the foundational tool that makes all insulin dosing decisions possible.
T1D vs T2D monitoring difference: While T2D monitoring tracks metabolic progress, T1D monitoring is an immediate safety tool — a missed reading or incorrect insulin dose can cause hypoglycemia (dangerous low blood sugar) within minutes or diabetic ketoacidosis (DKA) within hours. Monitoring frequency in T1D is 4–10+ times daily, not once weekly.
Long-acting insulin (glargine, detemir, degludec) provides background coverage over 12–24 hours — mimics the continuous low-level insulin secretion of a healthy pancreas
Fast-acting insulin (lispro, aspart, glulisine) taken before meals — dosed based on carbohydrate count and current glucose level
Personal ratio (e.g., 1 unit per 15g carbs) determines bolus dose — requires accurate glucose reading before every meal
Units of insulin needed to lower glucose by a target amount (e.g., 1 unit drops glucose 50 mg/dL) — used when glucose is elevated
Glucose below 70 mg/dL requires immediate treatment with fast-acting carbohydrates (15g rule) — accurate low-range glucometer readings are critical
Illness increases insulin requirements and DKA risk — frequent monitoring every 2–4 hours with ketone testing required during illness
| Time Point | Target Range | Action Threshold | Clinical Significance |
|---|---|---|---|
| Fasting / Pre-meal | 80–130 mg/dL | <70 or >180 mg/dL | Guides basal insulin dose adjustment |
| 2 hours post-meal | <180 mg/dL | >250 mg/dL persistent | Guides insulin-to-carb ratio adjustment |
| Bedtime | 90–150 mg/dL | <90 mg/dL | Hypoglycemia overnight risk if too low |
| HbA1c (3-month avg) | <7.0% (ADA); <6.5% (aggressive) | ≥8.0% — intensification needed | Reflects overall glucose control; complication risk indicator |
| Time In Range (TIR) | ≥70% in 70–180 mg/dL | <70% TIR — review management | Gold standard CGM metric; correlates with complications |
Check blood or urine ketones when glucose is above 250 mg/dL on two consecutive readings, when sick regardless of glucose, when experiencing nausea/vomiting/abdominal pain, or before exercise if glucose is above 250 mg/dL.
Glucose above 250 mg/dL + moderate/large ketones + nausea/vomiting/abdominal pain + rapid breathing = DKA emergency. Go to ER immediately — do not wait for glucose to come down at home.
Never skip basal insulin (even when not eating). Check glucose every 2–4 hours during illness. Keep ketone strips or a blood ketone meter available at all times.
Blood ketone meters (Keto-Mojo, Abbott Precision Xtra) measure beta-hydroxybutyrate — more accurate and detects DKA earlier than urine strips. Blood ketones above 1.5 mmol/L require physician contact; above 3.0 mmol/L = DKA emergency.
Correction insulin every 2–4 hours if glucose stays above 250 mg/dL. Never stop basal insulin during illness. Oral fluids if able; IV fluids at ER if vomiting prevents oral intake.
Pump site failures cause rapid glucose rise and DKA within hours — always have backup pen insulin available. Check site if glucose rises unexpectedly.
Measures interstitial glucose every 1–5 minutes, provides trend arrows (rising/falling rate), alarms for hypo and hyperglycemia — transforming T1D management
CGM enables Time In Range (TIR) measurement — percentage of time glucose is between 70–180 mg/dL. TIR above 70% is the current gold standard goal
Automated insulin delivery (AID) systems combine CGM with insulin pump — automatically adjust basal insulin based on real-time CGM data. FDA approved systems include Tandem Control-IQ and Medtronic 780G
CGM measures interstitial glucose (15-min lag vs blood). Calibration finger-prick required for some systems. Inaccurate during rapid glucose changes — verify with fingerstick before treating hypoglycemia
CGM is covered by Medicare and most commercial insurance for T1D — the Dexcom G7 and Abbott Libre 3 are the two most widely covered devices
#1 Pick: Contour Next One · Score: 9.7/10 · 5 products tested
A glucometer gives a single reading at the moment of the finger prick — a snapshot. A CGM (continuous glucose monitor) provides a new reading every 1–5 minutes automatically, all day and night, with trend arrows showing whether glucose is rising or falling and alarms when it goes too high or too low. For T1D, CGM is now the standard of care — it catches overnight hypoglycemia, prevents post-meal spikes, enables more precise insulin dosing, and dramatically improves quality of life. A glucometer remains essential as a backup for verifying low readings before treating hypoglycemia.
ISO 15197:2013 requires 95% of readings within ±15% of the reference value above 75 mg/dL and within ±15 mg/dL below 75 mg/dL. For T1D, low-range accuracy is most critical — at 60 mg/dL, a 15% error means the reading could show anywhere from 51–69 mg/dL. That difference changes whether you treat a hypoglycemia with 15g carbs or correct an apparent low that is actually 69 mg/dL. Choose meters with the best low-range accuracy ratings (Contour Next consistently tops these studies).
Always use a glucometer (fingerstick) to verify a CGM reading before treating hypoglycemia — CGM measures interstitial glucose with a 15-minute lag and can be inaccurate during rapid glucose changes. The rule: if your CGM reads below 70 mg/dL and you feel symptoms, treat immediately with 15g fast carbs. If you don't feel symptoms and the CGM reads low, verify with a finger prick before treating. Also fingerstick when CGM readings seem inconsistent with symptoms or when making any insulin dose decision based on a questionable CGM reading.
Check for ketones (blood or urine). Give a correction insulin dose per your physician's instructions. Drink water. Recheck glucose in 2 hours. If glucose remains above 250 mg/dL after 2 correction doses, check your insulin pump site (if using a pump) or switch insulin pens. If ketones are moderate or large, contact your endocrinologist immediately — this is the beginning of DKA, which requires emergency treatment if it progresses.
Yes — the glucometers are the same devices. The difference is frequency of use (T1D: 6–10 times daily; T2D: often once daily or less), the integration with insulin pumps, and the critical importance of low-range accuracy for T1D hypoglycemia management. For T1D patients who cannot access CGM, any ISO 15197:2013 certified glucometer works — the Contour Next One's superior low-range accuracy makes it particularly appropriate for T1D.
Every Tuesday we send you the single most useful review we published that week. No spam, no affiliate pitches, no clickbait — just the work.